Skip to content
Quebec News Tribune – Lifestyle
Author:
ImmunoBrain Checkpoint Inc.
ImmunoBrain Announces Nature Medicine Publication and Late-Breaking AAIC 2026 Presentation for IBC-Ab002 in Early Alzheimer’s Disease
July 14, 2026
ImmunoBrain Presents Clinical Data for First Immune Checkpoint Therapy Approach in Alzheimer’s Disease at AD/PD™ 2026
March 19, 2026
ImmunoBrain to Present Topline Phase 1b Clinical Data for Immune Checkpoint Treatment in Alzheimer’s Disease at AD/PD™ 2026
March 12, 2026